A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

Completed

Phase 2 Results

Results

ARTIST + (Phase III) was abandoned after failing an interim futility analysis.